RxDoctor Payments Data

Richard Powers, MD

Family Medicine · Columbia, TNNPI 1467428680

Payments from drug & device makers

$3,480in general payments, 2019–2025

Across 202 payments — averaging $17.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$402
  • Novo Nordisk$388
  • Pfizer$299
  • Lilly USA, LLC$254
  • Dexcom, Inc.$231
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$156
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$3,480100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,480 in reported general payments places this provider in the 75th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$212,302
Medicare patients
570
Services billed
7,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin157$117,004
MounjaroTirzepatide44$64,008
OzempicSemaglutide38$61,023
EliquisApixaban52$60,194
TrulicityDulaglutide58$56,636
FarxigaDapagliflozin Propanediol22$23,869
RybelsusSemaglutide15$19,292
XareltoRivaroxaban24$16,281
JanuviaSitagliptin Phosphate12$13,104
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,615
Icosapent Ethyl35$8,464
Febuxostat30$6,529
VascepaIcosapent Ethyl16$5,636
Atorvastatin Calcium433$4,559
Rosuvastatin Calcium232$4,323

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$254$120,644102 claims
Boehringer IngelheimJardiance$92$117,004157 claims
Novo NordiskOzempic, Rybelsus$388$80,31553 claims
PfizerEliquis$299$60,19452 claims
AstraZenecaFarxiga$132$23,86922 claims
Johnson & JohnsonXarelto$38$16,28124 claims
MerckJanuvia$89$13,10412 claims
GSKTrelegy Ellipta$130$8,61514 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Columbia

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →